siRNA targeting transducin (beta)-like 3 (TBL3)
US7576196B2 · kind B2 · utility
56Cited by
10References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 14, 2008 |
| Grant date | Aug 18, 2009 |
| Priority date | — |
| Expiry date | Oct 14, 2028 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/11
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Efficient sequence specific gene silencing is possible through the use of siRNA technology. By selecting particular siRNAs by rational design, one can maximize the generation of an effective gene silencing reagent, as well as methods for silencing genes. Methods, compositions, and kits generated through rational design of siRNAs are disclosed including those directed to nucleotide sequences for TBL3.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.